Semra Özdemir

  • Citations Per Year
Learn More
BACKGROUND Crohn's disease is a serious and debilitating gastrointestinal disorder with a high, unmet need for new treatments. Biologic agents have the potential to alter the natural course of Crohn's disease but present known risks of potential serious adverse events (SAEs). Previous studies have shown that patients are willing to accept elevated SAE risks(More)
Weighing the benefits and risks of new health technologies requires assessing the available scientific evidence but also making societal value judgments about the relative importance of those benefits and risks [1]. Such judgments traditionally have been delegated to physicians. Increasingly, however, patients are claiming a greater role in such(More)
  • 1